Updated: February 10, 2026
How to Help Your Patients Find Epinephrine in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- Step 1: Use Device-Agnostic Prescribing as Your Default
- Step 2: Know the Full Menu of Available Products
- Step 3: Build a Standard Callback Protocol for Pharmacy Unavailability
- Step 4: Proactively Address Cost Barriers at Every Renewal
- Step 5: Prepare Allergy Action Plans for Device Flexibility
- Using medfinder in Your Practice
- Key Provider Checklist: Epinephrine Access
A practical guide for healthcare providers on helping patients find epinephrine in stock in 2026, including prescribing tips, savings programs, and workflow tools.
When a patient with severe allergies calls your office unable to fill their epinephrine prescription, it creates a clinical urgency that disrupts your day — and puts them at risk. This guide gives you the practical tools to reduce those calls, improve patient access, and handle availability issues efficiently when they do arise.
Step 1: Use Device-Agnostic Prescribing as Your Default
The single most impactful prescribing change you can make is writing 'epinephrine auto-injector' rather than a specific brand name unless you have a clinical reason to specify. When a prescription is written generically, pharmacists in most states can dispense whichever approved product they have in stock — eliminating the need for a callback when one product is unavailable.
Caveat: Some states require a new prescription to substitute between different auto-injector devices. Check your state's Board of Pharmacy rules. If your state restricts automatic substitution, educate patients upfront that if EpiPen is unavailable, they should call your office for an alternate prescription — and make this a quick turnaround.
Step 2: Know the Full Menu of Available Products
Being familiar with all available options makes it faster to help when a patient hits a stockout. Here's a quick reference:
EpiPen / EpiPen Jr (Viatris): 0.3 mg (≥30 kg) and 0.15 mg (15–30 kg); standard 2-pack auto-injector
Authorized generic (Viatris): Same as EpiPen; 40–50% less expensive; substitute by asking for 'authorized generic'
Auvi-Q (Kaléo): 0.1 mg (7.5–<15 kg), 0.15 mg (15–<30 kg), 0.3 mg (≥30 kg); voice-guided; $0 copay for commercially insured
Adrenaclick / generic: 0.15 mg and 0.3 mg; two-step activation; often lowest cash price
Symjepi (Adamis): 0.15 mg and 0.3 mg prefilled syringe; smaller form factor
neffy (ARS Pharma): Epinephrine nasal spray; FDA-approved August 2024; needle-free option
Step 3: Build a Standard Callback Protocol for Pharmacy Unavailability
Reduce the burden on your staff by establishing a clear protocol for the recurring scenario of 'patient can't find epinephrine at their pharmacy':
Patient calls. Staff member notes which product is unavailable and which pharmacies they've checked.
Staff refers patient to medfinder to locate an in-stock pharmacy without tying up your phone lines.
If medfinder identifies an alternative product in stock, provider or clinical staff sends an alternate prescription to that pharmacy — same-day turnaround.
When issuing an alternate product, confirm patient is aware of how the new device works and that a trainer device is included.
Step 4: Proactively Address Cost Barriers at Every Renewal
Cost-driven non-adherence — patients not refilling epinephrine because they can't afford it — is a life-threatening clinical problem. Build cost-management into your renewal workflow:
Ask at every renewal: 'Have you had any difficulty filling your epinephrine prescription or affording it?' Many patients don't volunteer cost concerns.
If insured: Direct them to the Auvi-Q $0 copay program or the Viatris EpiPen Savings Card. These can dramatically reduce out-of-pocket costs.
If uninsured: Refer to Viatris Patient Assistance Program, NeedyMeds, or RxAssist. Prescribing the generic Adrenaclick as cash-pay option (~$150–$200 with discount cards) may also help.
Keep printed materials in your office: Have printed information on savings programs ready to hand to patients who express cost concerns.
Step 5: Prepare Allergy Action Plans for Device Flexibility
Allergy action plans submitted to schools, daycares, and workplaces should be written to accommodate whichever epinephrine device the patient currently has. Best practice recommendations:
Reference the generic medication name (epinephrine) rather than a specific brand on the action plan
Include instructions for the specific device the patient currently has, with a note that instructions may differ if a different device is dispensed
Update the action plan any time the patient's epinephrine device changes
Using medfinder in Your Practice
medfinder is a service that calls pharmacies near a patient to identify which ones have a specific medication in stock, then texts results directly to the patient. medfinder for providers is designed to integrate into your patient communication workflow — reducing the number of callbacks your staff has to handle when patients can't fill epinephrine prescriptions.
Key Provider Checklist: Epinephrine Access
Write device-agnostic epinephrine prescriptions as default
Know weight-based dosing for all available epinephrine products
Address cost barriers at every prescription renewal
Establish a callback protocol for pharmacy unavailability that uses medfinder
Verify device technique whenever a patient switches epinephrine products
Update allergy action plans to accommodate device flexibility
For a deeper look at the supply landscape and shortage history, see our full epinephrine shortage briefing for providers.
Frequently Asked Questions
Write device-agnostic prescriptions so pharmacists can substitute whatever is in stock without needing a callback. Refer patients who hit stockouts to medfinder, which calls nearby pharmacies to find availability. Build a clear staff protocol for handling unavailability calls so they can resolve most cases without involving the provider directly.
Kaléo offers a program that allows commercially insured patients to receive Auvi-Q at $0 out-of-pocket. Patients can access this through Kaléo's website or by calling their support line. This is one of the most generous copay programs in the epinephrine category and makes Auvi-Q effectively free for most commercially insured patients.
Yes, always. EpiPen, Auvi-Q, and Adrenaclick all have different activation mechanisms. An allergy action plan that specifies EpiPen instructions won't be helpful if a patient now carries Auvi-Q. Update the plan and ensure schools, daycares, and family members are aware of how the new device works.
Start with the Auvi-Q $0 copay program (for commercially insured patients) or the Viatris EpiPen Savings Card (up to $25/device for insured). For uninsured patients, the Viatris Patient Assistance Program provides free EpiPen for qualifying individuals. Prescribing generic Adrenaclick as a cash-pay option (~$150-$200 per 2-pack with discount cards) is another affordable path.
neffy (epinephrine nasal spray, FDA-approved August 2024) is a reasonable option for patients who are needle-phobic, have dexterity issues, or prefer a needle-free delivery method. Whether it is appropriate as a first-line option versus an auto-injector depends on individual patient factors and should be evaluated according to current allergy society guidelines. Discuss with your patient to understand their preference and situation.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Epinephrine also looked for:
More about Epinephrine
32,873 have already found their meds with Medfinder.
Start your search today.





